BIOLARGO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3509 USD | +0.29% |
|
+3.33% | +108.87% |
| 02/04 | Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024 | |
| 01/04 | BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on BioLargo, Inc.
Price target over the last 5 years
History of analyst recommendation changes
5e1c761638ad98d2345bd4172cc.WkIBQhtGtGv6eU9SZL6Rrs4epuHRaU1jdapxmUXyMMo.HnU0cH9w5gWQQCYGNovi-fZW-avpHSQgTeUn_XeBA5soC1UXaTb_WcIQOA~194160d0e34afcc151503280bb8e4fea
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3509
USD
Average target price
0.35
USD
Spread / Average Target
-0.26%
High Price Target
0.35
USD
Spread / Highest target
-0.26%
Low Price Target
0.35
USD
Spread / Lowest Target
-0.26%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- BLGO Stock
- Consensus BioLargo, Inc.